Kimberly Davies, MD

Program Leader for Pediatric Oncology Clinical Services, Boston Children's Hospital Institute Physician
Assistant Professor of Pediatrics, Harvard Medical School
Kimberly Davies, MD
Phone 888-733-4662
Fax 617-632-5710
NPI 1487621199
Print Profile
Request an Appointment
View Research Profile
Locations

Kimberly Davies, MD

Program Leader for Pediatric Oncology Clinical Services, Boston Children's Hospital Institute Physician
Assistant Professor of Pediatrics, Harvard Medical School

Medical Services

Programs & Services
Hematologic Malignancy Center
Lymphoma Program
Conditions & Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Pediatric and Childhood Cancers
Languages
English
Education
Medical School
University of California, Los Angeles School of Medicine
1986
Los Angeles
CA
Internship
Boston Children's Hospital
1987
Boston
MA
Residency
Boston Children's Hospital
1989
Boston
MA
Fellowship
Boston Children's Hospital / Dana Farber Cancer Institute
1992
Boston
MA
Certifications
American Board of Pediatrics (Hematology-Oncology)

Publications

Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance. View Abstract
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. View Abstract
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. View Abstract
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. View Abstract
Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. View Abstract
Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. View Abstract
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. View Abstract
A Quality Improvement Initiative to Increase and Sustain Influenza Vaccination Rates in Pediatric Oncology and Stem Cell Transplant Patients. View Abstract
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. View Abstract
Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. View Abstract
Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study. View Abstract
Myogenic tumors in nevoid Basal cell carcinoma syndrome. View Abstract
Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. View Abstract
Avulsive cortical irregularity and F-18 FDG PET. View Abstract
Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. View Abstract
Complex Interplay between Three Proximal Cis-Acting Regulatory Sites Dictate the T Cell Specific Expression of Human Interleukin 3 (IL3)(Abstract) View Abstract
Locations